Inventor
DOYLE TERRENCE W
US45 patents
⚠️ This page may combine multiple inventors who share the name “DOYLE TERRENCE W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS CO
34 patentsUS4866180ASep 12, 1989
Amino disulfide thiol exchange products
BRISTOL MYERS CO39 citations92
US4552842ANov 12, 1985
Process for producing rebeccamycin
BRISTOL MYERS CO33 citations91
US4487925ADec 11, 1984
Rebeccamycin and process for its preparation
BRISTOL MYERS CO20 citations81
US4814445AMar 21, 1989
Process for preparing mitomycin analogs
BRISTOL MYERS CO8 citations74
US4487769ADec 11, 1984
Amidines
BRISTOL MYERS CO9 citations74
US4012383AMar 15, 1977
Δ2,3 -1,4-morpholine-2-carboxylic acids and derivatives thereof useful in preparation of antibacteria agents
BRISTOL MYERS CO9 citations72
US4598145AJul 1, 1986
Albacarcins V and M
BRISTOL MYERS CO9 citations71
US4927943AMay 22, 1990
Substituted 7-oxomitosanes
BRISTOL MYERS CO4 citations63
US4803212AFeb 7, 1989
Amino disulfides
BRISTOL MYERS CO4 citations63
US4692538ASep 8, 1987
Trichloroethanimidic acid esters
BRISTOL MYERS CO2 citations63
US4691023ASep 1, 1987
Amino disulfides
BRISTOL MYERS CO4 citations63
US4567256AJan 28, 1986
Amidine process
BRISTOL MYERS CO4 citations63
US4189568AFeb 19, 1980
Antibiotic purification process
BRISTOL MYERS CO4 citations63
US4642352AFeb 10, 1987
Acylamino mitosanes
BRISTOL MYERS CO3 citations62
US4413134ANov 1, 1983
Triacylated derivative of scirpentriol
BRISTOL MYERS CO2 citations61
US4332732AJun 1, 1982
Antitumor agents
BRISTOL MYERS CO3 citations61
US4267113AMay 12, 1981
Antitumor agents
BRISTOL MYERS CO5 citations61
US4172199AOct 23, 1979
O-2-isocephem-4-carboxylic acid derivatives as antibacterial agents
BRISTOL MYERS CO3 citations61
US4123608AOct 31, 1978
Antibiotic compound
BRISTOL MYERS CO2 citations61
US4113946ASep 12, 1978
Δ2,3 -1,4-Morpholine-2-carboxylic acid derivatives as antibacterial agents
BRISTOL MYERS CO2 citations61
US4066831AJan 3, 1978
O-2-Isocephem-4-carboxylic acid derivatives as antibacterial agents
BRISTOL MYERS CO1 citations61
US4065623ADec 27, 1977
O-2-Isocephem-4-carboxylic acid derivatives as antibacterial agents
BRISTOL MYERS CO3 citations61
US4461831AJul 24, 1984
Antitumor agents albacarcins V and M
BRISTOL MYERS CO4 citations60
US5099016AMar 24, 1992
Substituted 7-oxomitosanes
BRISTOL MYERS CO0 citations52
US5097036AMar 17, 1992
Substituted 7-oxomitosanes
BRISTOL MYERS CO0 citations52
US4767863AAug 30, 1988
Isoxazoline intermediates
BRISTOL MYERS CO0 citations52
US4579737AApr 1, 1986
Bis-amidines
BRISTOL MYERS CO1 citations52
US4552971ANov 12, 1985
3α,15-Bis(chloroacetoxy)-4.beta.-hydroxy-12,13-epoxytrichothec-9-ene useful as an antitumor agent
BRISTOL MYERS CO1 citations51
US4456765AJun 26, 1984
Trichothec-9-ene-3,4,15-triol,12,13-epoxy-3-chloroacetate useful as an anti-tumor agent
BRISTOL MYERS CO1 citations51
US4433158AFeb 21, 1984
3-Hydroxyiminoscirpen-4β, 15-diol esters useful as antitumor agents
BRISTOL MYERS CO1 citations51
US4332951AJun 1, 1982
Antitumor agents
BRISTOL MYERS CO0 citations51
US4284568AAug 18, 1981
Antitumor agents
BRISTOL MYERS CO1 citations51
US4162938AJul 31, 1979
Antibiotic compound
BRISTOL MYERS CO0 citations45
US4590074AMay 20, 1986
Bis-amidines
BRISTOL MYERS CO0 citations42
VION PHARMACEUTICALS INC
5 patentsUS6855695B2Feb 15, 2005
Water-soluble SHPs as novel alkylating agents
VION PHARMACEUTICALS INC26 citations90
US5767134AJun 16, 1998
Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP
VION PHARMACEUTICALS INC37 citations89
US5869676AFeb 9, 1999
Process for the synthesis of ribonucleotide reductase inhibitors 3-AP and 3-AMP
VION PHARMACEUTICALS INC13 citations70
US6458816B1Oct 1, 2002
Modified prodrug forms of AP/AMP
VION PHARMACEUTICALS INC6 citations59
US7405317B2Jul 29, 2008
Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents
VION PHARMACEUTICALS INC3 citations56